BILL NUMBER: SB 493	AMENDED
	BILL TEXT

	AMENDED IN SENATE  APRIL 1, 2013

INTRODUCED BY   Senator Hernandez

                        FEBRUARY 21, 2013

   An act to amend  Section   4050 of
  Sections 733, 4050, 4051, 4052, 4052.3, and 4060 of,
and to add Sections 4016.5, 4052.6, 4052.8, 4052.9, 4210, and 4233
to,  the Business and Professions Code, relating to 
pharmacies   pharmacy  .


	LEGISLATIVE COUNSEL'S DIGEST


   SB 493, as amended, Hernandez. Pharmacy practice.
   The Pharmacy Law provides for the licensing and regulation of
pharmacists by the California State Board of Pharmacy in the
Department of Consumer Affairs  , and states that pharmacy
practice is a dynamic, patient-oriented health service that applies a
scientific body of knowledge to improve and promote patient health
by means of appropriate drug use and drug-related therapy  .
 The law specifies the functions pharmacists are authorized to
perform, including to administer, orally or topically, drugs and
biologicals pursuant to a prescriber's order, and to administer
immunizations pursuant to a protocol with a prescriber. Pharmacists
may also furnish emergency contraception drug therapy pursuant to
standardized procedures if   they have completed a training
program. A violation of the Pharmacy Law is a crime.  
   This bill would make a technical, nonsubstantive change to that
provision.  
   This bill, instead, would authorize a pharmacist to administer
drugs and biological products that have been ordered by a prescriber.
The bill would expand other functions pharmacists are authorized to
perform, including, among other things, to furnish self-administered
hormonal contraceptives, prescription smoking-cessation drugs, and
prescription medications not requiring a diagnosis that are
recommended for international travelers, as specified. Additionally,
the bill would authorize pharmacists to order and interpret tests for
the purpose of monitoring and managing the efficacy and toxicity of
drug therapies, and to independently initiate and administer routine
vaccinations, as specified. This bill also would establish board
recognition for an advanced practice pharmacist, as defined, would
specify the criteria for that recognition, and would specify
additional functions that may be performed by an advanced practice
pharmacist, including, among other things, performing physical
assessments, and certain other functions, as specified. Because a
violation of these provisions would be a crime, the bill would impose
a state-mandated local program.  
   The bill would make other conforming and technical changes. 

   The California Constitution requires the state to reimburse local
agencies and school districts for certain costs mandated by the
state. Statutory provisions establish procedures for making that
reimbursement.  
   This bill would provide that no reimbursement is required by this
act for a specified reason. 
   Vote: majority. Appropriation: no. Fiscal committee:  no
  yes  . State-mandated local program:  no
  yes  .


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

   SECTION 1.    Section 733 of the   Business
and Professions Code   is amended to read: 
   733.  (a)  No   A  licentiate shall 
not  obstruct a patient in obtaining a prescription drug or
device that has been legally prescribed or ordered for that patient.
A violation of this section constitutes unprofessional conduct by the
licentiate and shall subject the licentiate to disciplinary or
administrative action by his or her licensing agency.
   (b) Notwithstanding any other  provision of  law,
a licentiate shall dispense drugs and devices, as described in
subdivision (a) of Section 4024, pursuant to a lawful order or
prescription unless one of the following circumstances exists:
   (1) Based solely on the licentiate's professional training and
judgment, dispensing pursuant to the order or the prescription is
contrary to law, or the licentiate determines that the prescribed
drug or device would cause a harmful drug interaction or would
otherwise adversely affect the patient's medical condition.
   (2) The prescription drug or device is not in stock. If an order,
other than an order described in Section 4019, or prescription cannot
be dispensed because the drug or device is not in stock, the
licentiate shall take one of the following actions:
   (A) Immediately notify the patient and arrange for the drug or
device to be delivered to the site or directly to the patient in a
timely manner.
   (B) Promptly transfer the prescription to another pharmacy known
to stock the prescription drug or device that is near enough to the
site from which the prescription or order is transferred, to ensure
the patient has timely access to the drug or device.
   (C) Return the prescription to the patient and refer the patient.
The licentiate shall make a reasonable effort to refer the patient to
a pharmacy that stocks the prescription drug or device that is near
enough to the referring site to ensure that the patient has timely
access to the drug or device.
   (3) The licentiate refuses on ethical, moral, or religious grounds
to dispense a drug or device pursuant to an order or prescription. A
licentiate may decline to dispense a prescription drug or device on
this basis only if the licentiate has previously notified his or her
employer, in writing, of the drug or class of drugs to which he or
she objects, and the licentiate's employer can, without creating
undue hardship, provide a reasonable accommodation of the licentiate'
s objection. The licentiate's employer shall establish protocols that
ensure that the patient has timely access to the prescribed drug or
device despite the licentiate's refusal to dispense the prescription
or order. For purposes of this section, "reasonable accommodation"
and "undue hardship" shall have the same meaning as applied to those
terms pursuant to subdivision (l) of Section 12940 of the Government
Code.
   (c) For the purposes of this section, "prescription drug or device"
has the same meaning as the definition in Section 4022.
   (d)  The provisions of this section shall apply to the
  This   section applies to emergency
contraception  drug therapy  and self-administered hormonal
contraceptives  described in Section 4052.3.
   (e) This section imposes no duty on a licentiate to dispense a
drug or device pursuant to a prescription or order without payment
for the drug or device, including payment directly by the patient or
through a third-party payer accepted by the licentiate or payment of
any required copayment by the patient.
   (f) The notice to consumers required by Section 4122 shall include
a statement that describes patients' rights relative to the
requirements of this section.
   SEC. 2.    Section 4016.5 is added to the  
Business and Professions Code   , to read:  
   4016.5.  "Advanced practice pharmacist" means a licensed
pharmacist who has been recognized as an advanced practice pharmacist
by the board, pursuant to Section 4210. A board-recognized advanced
practice pharmacist is entitled to practice advanced practice
pharmacy as described in Section 4052.6, within or outside of a
licensed pharmacy as authorized by this chapter. 
   SECTION 1.   SEC. 3.   Section 4050 of
the Business and Professions Code is amended to read:
   4050.  (a) In recognition of and consistent with the decisions of
the appellate courts of this state, the Legislature hereby declares
the practice of pharmacy to be a profession.
   (b) Pharmacy practice is a dynamic, patient-oriented health
service that applies a scientific body of knowledge to improve and
promote patient health by means of appropriate drug use, drug-related
therapy, and communication for clinical and consultative purposes.
Pharmacy practice is continually evolving to include more
sophisticated and comprehensive patient care activities. 
   (c) The Legislature further declares that pharmacists are health
care providers who have the authority to provide health care
services. 
   SEC. 4.    Section 4051 of the   Business
and Professions Code   is amended to read: 
   4051.  (a) Except as otherwise provided in this chapter, it is
unlawful for any person to manufacture, compound, furnish, sell, or
dispense  any   a  dangerous drug or
dangerous device, or to dispense or compound  any 
 a  prescription pursuant to Section 4040 of a prescriber
unless he or she is a pharmacist under this chapter.
   (b) Notwithstanding any other law, a pharmacist may authorize the
initiation of a prescription, pursuant to Section 4052.1, 4052.2,
 or  4052.3,  or 4052.6,  and otherwise
provide clinical advice  or   , services, 
information  ,  or patient consultation  , as set forth
in this chapter,  if all of the following conditions are met:
   (1) The clinical advice  or   ,  
services,  information  ,  or patient consultation is
provided to a health care professional or to a patient.
   (2) The pharmacist has access to prescription, patient profile, or
other relevant medical information for purposes of patient and
clinical consultation and advice.
   (3) Access to the information described in paragraph (2) is secure
from unauthorized access and use.
   SEC. 5.    Section 4052 of the   Business
and Professions Code   is amended to read: 
   4052.  (a) Notwithstanding any other  provision of
 law, a pharmacist may:
   (1) Furnish a reasonable quantity of compounded drug product to a
prescriber for office use by the prescriber.
   (2) Transmit a valid prescription to another pharmacist.
   (3) Administer  , orally or topically, drugs and
biologicals pursuant to a prescriber's order   drugs and
biological   products that have been ordered by a
prescriber  .
   (4) Perform procedures or functions in a licensed health care
facility as authorized by Section 4052.1.
   (5) Perform procedures or functions as part of the care provided
by a health care facility, a licensed home health agency, a licensed
clinic in which there is a physician oversight, a provider who
contracts with a licensed health care service plan with regard to the
care or services provided to the enrollees of that health care
service plan, or a physician, as authorized by Section 4052.2. 
   (6) Perform procedures or functions as authorized by Section
4052.6.  
   (6) 
    (7)  Manufacture, measure, fit to the patient, or sell
and repair dangerous devices ,  or furnish instructions to
the patient or the patient's representative concerning the use of
those devices. 
   (7) 
    (8)  Provide consultation  , training, and education
 to patients  and   about drug therapy,
disease management, and disease prevention. 
    (9)     Provide  professional
information, including clinical or pharmacological information,
advice, or consultation to other health care professionals  , and
participate in multidisciplinary review of patient progress,
including appropriate access to medical records  . 
   (8) Furnish emergency  
   (10) Furnish the following medications: 
    (A)     Emergency  contraception drug
therapy  and self-administered hormonal contraceptives,  as
authorized by Section 4052.3. 
   (B) Prescription smoking-cessation drugs and devices, as
authorized by Section 4052.9.  
   (C) Prescription medications not requiring a diagnosis that are
recommended by the federal Centers for Disease Control and Prevention
for individuals traveling outside of the United States. 

   (9)
    (11)  Administer immunizations pursuant to a protocol
with a prescriber. 
   (12) Order and interpret tests for the purpose of monitoring and
managing the efficacy and toxicity of drug therapies. 
   (b) A pharmacist who is authorized to issue an order to initiate
or adjust a controlled substance therapy pursuant to this section
shall personally register with the federal Drug Enforcement
Administration. 
   (c) Nothing in this section shall affect the requirements of
existing law relating to maintaining the confidentiality of medical
records.  
   (d) Nothing in this section shall affect the requirements of
existing law relating to the licensing of a health care facility.
 
   (c) This section does not affect the applicable requirements of
law relating to either of the following:  
   (1) Maintaining the confidentiality of medical records.  

   (2) The licensing of a health care facility. 
   SEC. 6.    Section 4052.3 of the   Business
and Professions Code   is amended to read: 
   4052.3.  (a)  (1)     Notwithstanding any
other law, a pharmacist may furnish self-administered hormonal
contraceptives in accordance with standardized procedures or
protocols developed and approved by both the board and the Medical
Board of California in consultation with the American Congress of
Obstetricians and Gynecologists, the California Pharmacists
Association, and other appropriate entities. The standardized
procedure or protocol shall require that the patient use a
self-screening tool, based on the United States Medical Eligibility
Criteria (USMEC) for Contraceptive Use developed by the federal
Centers for Disease Control and Prevention, and that the pharmacist
refer the patient to the patient's primary care provider or, if 
 the patient does not have a primary care provider, to nearby
clinics.  
   (2) The board and the Medical Board of California are both
authorized to ensure compliance with this subdivision, and each board
is specifically charged with the enforcement of this subdivision
with respect to its respective licensees. This subdivision does not
expand the authority of a pharmacist to prescribe any prescription
medication. 
    (b)   (1)    Notwithstanding any other
 provision of  law, a pharmacist may furnish
emergency contraception drug therapy in accordance with either of the
following: 
   (1) 
    (A)  Standardized procedures or protocols developed by
the pharmacist and an authorized prescriber who is acting within his
or her scope of practice. 
   (2) 
    (B)  Standardized procedures or protocols developed and
approved by both the board and the Medical Board of California in
consultation with the American  College 
Congress  of Obstetricians and Gynecologists, the California
 Pharmacist   Pharmacists  Association, and
other appropriate entities.  Both the   The
 board and the Medical Board of California  shall have
authority   are both authorized  to ensure
compliance with this clause, and  both boards are 
 each board is  specifically charged with the enforcement of
this provision with respect to  their   its
 respective licensees.  Nothing in this clause shall be
construed to   This subdivision does not  expand
the authority of a pharmacist to prescribe any prescription
medication. 
   (b) 
    (2)  Prior to performing a procedure authorized under
this  paragraph   subdivision  , a
pharmacist shall complete a training program on emergency
contraception that consists of at least one hour of approved
continuing education on emergency contraception drug therapy.

   (c) 
    (3)  A pharmacist, pharmacist's employer, or pharmacist'
s agent  may   shall  not directly charge a
patient a separate consultation fee for emergency contraception drug
therapy services initiated pursuant to this  paragraph
  subdivision  , but may charge an administrative
fee not to exceed ten dollars ($10) above the retail cost of the
drug. Upon an oral, telephonic, electronic, or written request from a
patient or customer, a pharmacist or pharmacist's employee shall
disclose the total retail price that a consumer would pay for
emergency contraception drug therapy. As used in this 
subparagraph   paragraph  , total retail price
includes providing the consumer with specific information regarding
the price of the emergency contraception drugs and the price of the
administrative fee charged. This limitation is not intended to
interfere with other contractually agreed-upon terms between a
pharmacist, a pharmacist's employer, or a pharmacist's agent, and a
health care service plan or insurer. Patients who are insured or
covered and receive a pharmacy benefit that covers the cost of
emergency contraception shall not be required to pay an
administrative fee. These patients shall be required to pay
copayments pursuant to the terms and conditions of their coverage.
 The provisions of this subparagraph shall cease to be
operative   This paragraph shall become inoperative
 for dedicated emergency contraception drugs  when
  if  these drugs are reclassified as
over-the-counter products by the federal Food and Drug
Administration. 
   (d) 
    (4)  A pharmacist  may   shall
 not require a patient to provide individually identifiable
medical information that is not specified in Section 1707.1 of Title
16 of the California Code of Regulations before initiating emergency
contraception drug therapy pursuant to this  section
  subdivision  . 
   (e) 
    (c)  For each emergency contraception drug therapy 
or self-administered hormonal contraception  initiated pursuant
to this section, the pharmacist shall provide the recipient of the
 emergency contraception drugs   drug  with
a standardized factsheet that includes, but is not limited to, the
indications  and contraindications  for use of the drug, the
appropriate method for using the drug, the need for medical
followup, and other appropriate information. The board shall develop
this form in consultation with the State Department of Public Health,
the American  College   Congress  of
Obstetricians and Gynecologists, the California Pharmacists
Association, and other health care organizations.  The
provisions of this section do   This section does
not preclude the use of existing publications developed by nationally
recognized medical organizations.
   SEC. 7.    Section 4052.6 is added to the 
Business and Professions Code   , to read:  
   4052.6.  (a) A pharmacist recognized by the board as an advanced
practice pharmacist may do all of the following:
   (1) Perform physical assessments.
   (2) Order and interpret drug therapy-related tests.
   (3) Refer patients to other health care providers.
   (b) In addition to the authority provided in subdivision (a), a
pharmacist recognized as an advanced practice pharmacist who is
acting in collaboration with a patient's health care providers,
operating under a protocol with a physician, health care facility, or
health plan or disability insurer, or participating in a medical
home, accountable care organization, or other system of care, may do
both of the following:
   (1) Initiate, adjust, or discontinue drug therapy. As used in this
section, "adjust" means changing the dosage, duration, frequency, or
potency of a drug.
   (2) Participate in the evaluation and management of diseases and
health conditions in collaboration with other health care providers.
   (c) A pharmacist who adjusts or discontinues drug therapy shall
promptly transmit written notification to the patient's diagnosing
prescriber or enter the appropriate information in a patient record
system shared with the prescriber. A pharmacist who initiates drug
therapy shall promptly transmit written notification to, or enter the
appropriate information into, a patient record system shared with
the patient's primary care provider or diagnosing provider, as
appropriate.
   (d) This section shall not interfere with a physician's order to
dispense a prescription drug as written, or other order of similar
meaning.
   (e) Prior to initiating or adjusting a controlled substance
therapy pursuant to this section, a pharmacist shall personally
register with the federal Drug Enforcement Administration. 
   SEC. 8.    Section 4052.8 is added to the  
Business and Professions Code   , to read:  
   4052.8.  (a) In addition to the authority provided in paragraph
(9) of subdivision (a) of Section 4052, a pharmacist may
independently initiate and administer vaccines listed on the routine
immunization schedules recommended by the federal Advisory Committee
on Immunization Practices (ACIP), in compliance with individual ACIP
vaccine recommendations, and published by the federal Centers for
Disease Control and Prevention (CDC) for persons three years of age
and older.
   (b) In order to initiate and administer an immunization described
in subdivision (a), a pharmacist shall do all of the following:
   (1) Complete an immunization training program endorsed by the CDC
or the Accreditation Council for Pharmacy Education that, at a
minimum, includes hands-on injection technique, clinical evaluation
of indications and contraindications of vaccines, and the recognition
and treatment of emergency reactions to vaccines, and shall maintain
that training.
   (2) Be certified in basic life support.
   (3) Comply with all state and federal recordkeeping and reporting
requirements, including providing documentation to the patient's
primary care provider and entering information in the appropriate
immunization registry designated by the immunization branch of the
State Department of Public Health.
   (c) A pharmacist administering immunizations pursuant to this
section, or paragraph (9) of subdivision (a) of Section 4052, may
also initiate and administer epinephrine or diphenhydramine by
injection for the treatment of a severe allergic reaction. 
   SEC. 9.    Section 4052.9 is added to the  
Business and Professions Code   , to read:  
   4052.9.  A pharmacist may furnish prescription smoking-cessation
drugs and devices, and provide smoking-cessation services if all of
the following conditions are met:
   (a) The pharmacist maintains records of all prescription drugs and
devices furnished for a period of at least three years for purposes
of notifying other health care providers and monitoring the patient.
   (b) The pharmacist notifies the patient's primary care provider of
any drugs or devices furnished to the patient. If the patient does
not have a primary care provider, the pharmacist provides the patient
with a written record of the drugs or devices furnished and advises
the patient to consult a physician of the patient's choice.
   (c) The pharmacist is certified in smoking-cessation therapy by an
organization recognized by the board.
   (d) The pharmacist completes one hour of continuing education
focused on smoking-cessation therapy biennially. 
   SEC. 10.    Section 4060 of the   Business
and Professions Code   is amended to read: 
   4060.   No   A  person shall  not
 possess any controlled substance, except that furnished to a
person upon the prescription of a physician, dentist, podiatrist,
optometrist, veterinarian, or naturopathic doctor pursuant to Section
3640.7, or furnished pursuant to a drug order issued by a certified
nurse-midwife pursuant to Section 2746.51, a nurse practitioner
pursuant to Section 2836.1, a physician assistant pursuant to Section
3502.1, a naturopathic doctor pursuant to Section 3640.5, or a
pharmacist pursuant to  either  Section 4052.1
 or   ,  4052.2  , or 4052.6  .
This section  shall   does  not apply to
the possession of any controlled substance by a manufacturer,
wholesaler, pharmacy, pharmacist, physician, podiatrist, dentist,
optometrist, veterinarian, naturopathic doctor, certified
nurse-midwife, nurse practitioner, or physician assistant, 
when   if  in stock in containers correctly labeled
with the name and address of the supplier or producer. 
   Nothing in this section authorizes 
    This section does not authorize  a certified
nurse-midwife, a nurse practitioner, a physician assistant, or a
naturopathic doctor, to order his or her own stock of dangerous drugs
and devices.
   SEC. 11.    Section 4210 is added to the  
Business and Professions Code   , to read:  
   4210.  (a) A person who seeks recognition as an advanced practice
pharmacist shall meet all of the following requirements:
   (1) Hold an active license to practice pharmacy issued pursuant to
this chapter that is in good standing.
   (2) Satisfy any one of the following criteria:
   (A) Earn certification in a relevant area of practice from an
organization approved by a board-recognized accrediting agency or
another entity recognized by the board.
   (B) Complete a one-year postgraduate residency where at least 50
percent of the experience includes the provision of direct patient
care services with interdisciplinary teams.
   (C) Have actively managed patients for at least one year under a
collaborative practice agreement or protocol with a physician,
advanced practice pharmacist, pharmacist practicing collaborative
drug therapy management, or health system.
   (3) File an application with the board for recognition as an
advanced practice pharmacist.
   (4) Pay the applicable fee to the board.
   (b) An advanced practice pharmacist recognition issued pursuant to
this section shall be valid for two years, coterminous with the
certificate holder's license to practice pharmacy. 
   SEC. 12.    Section 4233 is added to the  
Business and Professions Code   , to read:  
   4233.  A pharmacist who is recognized as an advanced practice
pharmacist shall complete 10 hours of continuing education each
renewal cycle in addition to the requirements of Section 4231. The
subject matter shall be in one or more areas of practice relevant to
the pharmacist's clinical practice. 
   SEC. 13.    No reimbursement is required by this act
pursuant to Section 6 of Article XIII B of the California
Constitution because the only costs that may be incurred by a local
agency or school district will be incurred because this act creates a
new crime or infraction, eliminates a crime or infraction, or
changes the penalty for a crime or infraction, within the meaning of
Section 17556 of the Government Code, or changes the definition of a
crime within the meaning of Section 6 of Article XIII B of the
California Constitution.